Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.
Kevin K ZarrabiThomas J GallowayDouglas B FliederSameera S KumarJulia JuddJessica R BaumanPublished in: Head & neck (2022)
We bring attention to a novel assay and highlight its potential for use in the treatment paradigm of HPV-mediated oropharyngeal carcinoma.